These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15105929)

  • 1. The design and synthesis of a selective inhibitor of fucosyltransferase VI.
    Galan MC; Venot AP; Phillips RS; Boons GJ
    Org Biomol Chem; 2004 May; 2(9):1376-80. PubMed ID: 15105929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stachybotrydial, a potent inhibitor of fucosyltransferase and sialyltransferase.
    Lin TW; Chang WW; Chen CC; Tsai YC
    Biochem Biophys Res Commun; 2005 Jun; 331(4):953-7. PubMed ID: 15882970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and analysis of potential α1,3-fucosyltransferase inhibitors.
    Seelhorst K; Piernitzki T; Lunau N; Meier C; Hahn U
    Bioorg Med Chem; 2014 Nov; 22(22):6430-7. PubMed ID: 25438767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potent and highly selective inhibitor of human alpha-1,3-fucosyltransferase via click chemistry.
    Lee LV; Mitchell ML; Huang SJ; Fokin VV; Sharpless KB; Wong CH
    J Am Chem Soc; 2003 Aug; 125(32):9588-9. PubMed ID: 12904015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput identification of fucosyltransferase inhibitors using carbohydrate microarrays.
    Bryan MC; Lee LV; Wong CH
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3185-8. PubMed ID: 15149672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosyltransferase activity can be selectively modulated by chemical modifications of acceptor substrates.
    Galan MC; Dodson CS; Venot AP; Boons GJ
    Bioorg Med Chem Lett; 2004 May; 14(9):2205-8. PubMed ID: 15081009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of transition-state analogue inhibitors of alpha-1,3-fucosyltransferase.
    Mitchell ML; Tian F; Lee LV; Wong CH
    Angew Chem Int Ed Engl; 2002 Aug; 41(16):3041-4. PubMed ID: 12203452
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of human alpha-1,3-fucosyltransferase V: glycosidic cleavage occurs prior to nucleophilic attack.
    Murray BW; Wittmann V; Burkart MD; Hung SC; Wong CH
    Biochemistry; 1997 Jan; 36(4):823-31. PubMed ID: 9020780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of N-acetyllactosamine derivatives with variation in the aglycon moiety for the study of inhibition of sialyl Lewis x expression.
    Mong TK; Lee LV; Brown JR; Esko JD; Wong CH
    Chembiochem; 2003 Sep; 4(9):835-40. PubMed ID: 12964157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosyltransferase activity can be modulated by small conformational changes of acceptor substrates.
    Galan MC; Venot AP; Boons GJ
    Biochemistry; 2003 Jul; 42(28):8522-9. PubMed ID: 12859199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anomer-selective glycosidase inhibition by 2-N-alkylated 1-azafagomines.
    Lopez Lopez O; Bols M
    Chembiochem; 2007 Apr; 8(6):657-61. PubMed ID: 17352429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition kinetics of carba- and C-fucosyl analogues of GDP-fucose against fucosyltransferase V: implication for the reaction mechanism.
    Norris AJ; Whitelegge JP; Strouse MJ; Faull KF; Toyokuni T
    Bioorg Med Chem Lett; 2004 Feb; 14(3):571-3. PubMed ID: 14741245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of α1,6-fucosyltransferase inhibitors through the diversity-oriented syntheses of GDP-fucose mimics using the coupling between alkyne and sulfonyl azide.
    Manabe Y; Kasahara S; Takakura Y; Yang X; Takamatsu S; Kamada Y; Miyoshi E; Yoshidome D; Fukase K
    Bioorg Med Chem; 2017 Jun; 25(11):2844-2850. PubMed ID: 28284868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic syntheses and inhibitory activities of bisubstrate-type inhibitors of sialyltransferases.
    Hinou H; Sun XL; Ito Y
    J Org Chem; 2003 Jul; 68(14):5602-13. PubMed ID: 12839452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a sensitive separation and quantification method for sialyl Lewis X and Lewis X involving anion-exchange chromatography: biochemical characterization of alpha1-3 fucosyltransferase-VII.
    Miyashiro M; Furuya S; Sugita T
    J Biochem; 2004 Nov; 136(5):723-31. PubMed ID: 15632313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FRET-based direct and continuous monitoring of human fucosyltransferases activity: an efficient synthesis of versatile GDP-L-fucose derivatives from abundant D-galactose.
    Maeda T; Nishimura S
    Chemistry; 2008; 14(2):478-87. PubMed ID: 17929334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of fucosyltransferase and fucosidase inhibitors.
    Tu Z; Lin YN; Lin CH
    Chem Soc Rev; 2013 May; 42(10):4459-75. PubMed ID: 23588106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptor specificity of GDP-Fuc:Gal beta 1-->4GlcNAc-R alpha 3-fucosyltransferase VI (FucT VI) expressed in insect cells as soluble, secreted enzyme.
    De Vries T; Palcic MP; Schoenmakers PS; Van Den Eijnden DH; Joziasse DH
    Glycobiology; 1997 Oct; 7(7):921-7. PubMed ID: 9363434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemo-enzymatic synthesis of conformationally constrained oligosaccharides.
    Galan MC; Venot AP; Glushka J; Imberty A; Boons GJ
    Org Biomol Chem; 2003 Nov; 1(22):3891-9. PubMed ID: 14664380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel alpha1,2-fucosyltransferase of Escherichia coli O128:b12 and functional investigation of its common motif.
    Li M; Liu XW; Shao J; Shen J; Jia Q; Yi W; Song JK; Woodward R; Chow CS; Wang PG
    Biochemistry; 2008 Jan; 47(1):378-87. PubMed ID: 18078329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.